First-in-class diabetes drug 'effective' in late-stage trial

A drug that inhibits glucose reabsorption in the kidney improves glycaemic control when added to metformin in people with type 2 diabetes, a study has shown.

by
Dapagliflozin reduces blood glucose levels through a novel insulin-independent mechanism.
Dapagliflozin reduces blood glucose levels through a novel insulin-independent mechanism.

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package